APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Donepezil

North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.

Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.

Selected research

Market Outlook & Growth Opportunities

Global Donepezil Market Outlook and Growth Opportunities 2026

Report ID 173985600425 December 2025197 pages

Choose your research edition.

Industry ResearchDonepezil Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Donepezil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.

Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.

The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.

Read the full market overview

This report provides an overview of the global Donepezil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil Segment by Company

Eisai

Pfizer

Teva

Sandoz

Apotex

Dr Reddy's Laboratories

Sun Pharmaceutical

Hansoh Pharma

Cipla

ARK PHA.LTD

Jishengtang Pharma

Luoxin

Donepezil Segment by Type

5mg

10mg

23mg

Donepezil Segment by Application

Hospitals

Clinics

Drugstore

Donepezil Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Donepezil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Donepezil market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Donepezil significant trends, drivers, influence factors in global and regions.

6. To analyze Donepezil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Donepezil industry.

Chapter 3: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Donepezil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Donepezil in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Donepezil Industry Trends Table 2. Donepezil Industry Drivers Table 3. Donepezil Industry Opportunities and Challenges Table 4. Donepezil Industry Restraints Table 5. Global Donepezil Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Donepezil Revenue Share by Company (2021-2026) Table 7. Global Donepezil Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Donepezil Sales Volume Share by Company (2021-2026) Table 9. Global Donepezil Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Donepezil Company Ranking, (2024-2026) & (USD Million) Table 11. Global Donepezil Key Company Manufacturing Base & Headquarters Table 12. Global Donepezil Company, Product Type & Application Table 13. Global Donepezil Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5mg Table 18. Significant Companies of 10mg Table 19. Significant Companies of 23mg Table 20. Global Donepezil Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Donepezil Sales Volume by Type (2021-2026) & (M Units) Table 22. Global Donepezil Sales Volume by Type (2027-2032) & (M Units) Table 23. Global Donepezil Sales Volume Share by Type (2021-2026) Table 24. Global Donepezil Sales Volume Share by Type (2027-2032) Table 25. Global Donepezil Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Donepezil Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Donepezil Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Donepezil Sales Value Share by Type (2021-2026) Table 29. Global Donepezil Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Drugstore Table 33. Global Donepezil Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Donepezil Sales Volume by Application (2021-2026) & (M Units) Table 35. Global Donepezil Sales Volume by Application (2027-2032) & (M Units) Table 36. Global Donepezil Sales Volume Share by Application (2021-2026) Table 37. Global Donepezil Sales Volume Share by Application (2027-2032) Table 38. Global Donepezil Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Donepezil Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Donepezil Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Donepezil Sales Value Share by Application (2021-2026) Table 42. Global Donepezil Sales Value Share by Application (2027-2032) Table 43. Global Donepezil Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Donepezil Sales by Region (2021-2026) & (M Units) Table 45. Global Donepezil Sales Market Share by Region (2021-2026) Table 46. Global Donepezil Sales by Region (2027-2032) & (M Units) Table 47. Global Donepezil Sales Market Share by Region (2027-2032) Table 48. Global Donepezil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Donepezil Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Donepezil Sales Value Share by Region (2021-2026) Table 51. Global Donepezil Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Donepezil Sales Value Share by Region (2027-2032) Table 53. Global Donepezil Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Donepezil Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Donepezil Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Global Donepezil Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Donepezil Sales by Country (2021-2026) & (M Units) Table 58. Global Donepezil Sales Market Share by Country (2021-2026) Table 59. Global Donepezil Sales by Country (2027-2032) & (M Units) Table 60. Global Donepezil Sales Market Share by Country (2027-2032) Table 61. Global Donepezil Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Donepezil Sales Value Market Share by Country (2021-2026) Table 63. Global Donepezil Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Donepezil Sales Value Market Share by Country (2027-2032) Table 65. Eisai Company Information Table 66. Eisai Business Overview Table 67. Eisai Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Eisai Donepezil Product Portfolio Table 69. Eisai Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Pfizer Donepezil Product Portfolio Table 74. Pfizer Recent Development Table 75. Teva Company Information Table 76. Teva Business Overview Table 77. Teva Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Teva Donepezil Product Portfolio Table 79. Teva Recent Development Table 80. Sandoz Company Information Table 81. Sandoz Business Overview Table 82. Sandoz Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Sandoz Donepezil Product Portfolio Table 84. Sandoz Recent Development Table 85. Apotex Company Information Table 86. Apotex Business Overview Table 87. Apotex Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Apotex Donepezil Product Portfolio Table 89. Apotex Recent Development Table 90. Dr Reddy's Laboratories Company Information Table 91. Dr Reddy's Laboratories Business Overview Table 92. Dr Reddy's Laboratories Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Dr Reddy's Laboratories Donepezil Product Portfolio Table 94. Dr Reddy's Laboratories Recent Development Table 95. Sun Pharmaceutical Company Information Table 96. Sun Pharmaceutical Business Overview Table 97. Sun Pharmaceutical Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Sun Pharmaceutical Donepezil Product Portfolio Table 99. Sun Pharmaceutical Recent Development Table 100. Hansoh Pharma Company Information Table 101. Hansoh Pharma Business Overview Table 102. Hansoh Pharma Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Hansoh Pharma Donepezil Product Portfolio Table 104. Hansoh Pharma Recent Development Table 105. Cipla Company Information Table 106. Cipla Business Overview Table 107. Cipla Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Cipla Donepezil Product Portfolio Table 109. Cipla Recent Development Table 110. ARK PHA.LTD Company Information Table 111. ARK PHA.LTD Business Overview Table 112. ARK PHA.LTD Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. ARK PHA.LTD Donepezil Product Portfolio Table 114. ARK PHA.LTD Recent Development Table 115. Jishengtang Pharma Company Information Table 116. Jishengtang Pharma Business Overview Table 117. Jishengtang Pharma Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Jishengtang Pharma Donepezil Product Portfolio Table 119. Jishengtang Pharma Recent Development Table 120. Luoxin Company Information Table 121. Luoxin Business Overview Table 122. Luoxin Donepezil Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Luoxin Donepezil Product Portfolio Table 124. Luoxin Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Donepezil Distributors List Table 128. Donepezil Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Donepezil Product Image Figure 2. Global Donepezil Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Sales Value (2021-2032) & (US$ Million) Figure 4. Global Donepezil Sales (2021-2032) & (M Units) Figure 5. Global Donepezil Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Donepezil Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5mg Image Figure 10. 10mg Image Figure 11. 23mg Image Figure 12. Global Donepezil Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Donepezil Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Donepezil Sales Volume Share by Type (2021-2032) Figure 15. Global Donepezil Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Donepezil Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Donepezil Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Drugstore Image Figure 21. Global Donepezil Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Donepezil Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Donepezil Sales Volume Share by Application (2021-2032) Figure 24. Global Donepezil Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Donepezil Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Donepezil Sales Value Share by Application (2021-2032) Figure 27. Global Donepezil Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 28. Global Donepezil Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Donepezil Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Donepezil Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Donepezil Sales Value (2021-2032) & (US$ Million) Figure 32. North America Donepezil Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Donepezil Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Donepezil Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Donepezil Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Donepezil Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Donepezil Sales Value (2021-2032) & (US$ Million) Figure 38. South America Donepezil Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Donepezil Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Donepezil Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Donepezil Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Donepezil Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Donepezil Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Donepezil Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Donepezil Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
  • 23mg
Applications
  • Hospitals
  • Clinics
  • Drugstore
Companies covered
  • Eisai
  • Pfizer
  • Teva
  • Sandoz
  • Apotex
  • Dr Reddy's Laboratories
  • Sun Pharmaceutical
  • Hansoh Pharma
  • Cipla
  • ARK PHA.LTD
  • Jishengtang Pharma
  • Luoxin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Donepezil Sales Value (2021-2032)
  4. 1.2.2 Global Donepezil Sales Volume (2021-2032)
  5. 1.2.3 Global Donepezil Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Donepezil Market Dynamics
  1. 2.1 Donepezil Industry Trends
  2. 2.2 Donepezil Industry Drivers
  3. 2.3 Donepezil Industry Opportunities and Challenges
  4. 2.4 Donepezil Industry Restraints
3 Donepezil Market by Company
  1. 3.1 Global Donepezil Company Revenue Ranking in 2025
  2. 3.2 Global Donepezil Revenue by Company (2021-2026)
  3. 3.3 Global Donepezil Sales Volume by Company (2021-2026)
  4. 3.4 Global Donepezil Average Price by Company (2021-2026)
  5. 3.5 Global Donepezil Company Ranking (2024-2026)
  6. 3.6 Global Donepezil Company Manufacturing Base and Headquarters
  7. 3.7 Global Donepezil Company Product Type and Application
  8. 3.8 Global Donepezil Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Donepezil Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Donepezil Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Donepezil Market by Type
  1. 4.1 Donepezil Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 10mg
  4. 4.1.3 23mg
  5. 4.2 Global Donepezil Sales Volume by Type
  6. 4.2.1 Global Donepezil Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Donepezil Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Donepezil Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Donepezil Sales Value by Type
  10. 4.3.1 Global Donepezil Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Donepezil Sales Value by Type (2021-2032)
  12. 4.3.3 Global Donepezil Sales Value Share by Type (2021-2032)
5 Donepezil Market by Application
  1. 5.1 Donepezil Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Drugstore
  5. 5.2 Global Donepezil Sales Volume by Application
  6. 5.2.1 Global Donepezil Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Donepezil Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Donepezil Sales Value by Application
  10. 5.3.1 Global Donepezil Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil Sales Value by Application (2021-2032)
  12. 5.3.3 Global Donepezil Sales Value Share by Application (2021-2032)
6 Donepezil Regional Sales and Value Analysis
  1. 6.1 Global Donepezil Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil Sales by Region: 2021-2026
  4. 6.2.2 Global Donepezil Sales by Region (2027-2032)
  5. 6.3 Global Donepezil Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Donepezil Sales Value by Region (2021-2032)
  7. 6.4.1 Global Donepezil Sales Value by Region: 2021-2026
  8. 6.4.2 Global Donepezil Sales Value by Region (2027-2032)
  9. 6.5 Global Donepezil Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Donepezil Sales Value (2021-2032)
  12. 6.6.2 North America Donepezil Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Donepezil Sales Value (2021-2032)
  15. 6.7.2 Europe Donepezil Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Donepezil Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Donepezil Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Donepezil Sales Value (2021-2032)
  21. 6.9.2 South America Donepezil Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Donepezil Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Donepezil Sales Value Share by Country, 2025 VS 2032
7 Donepezil Country-level Sales and Value Analysis
  1. 7.1 Global Donepezil Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Donepezil Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Donepezil Sales by Country (2021-2032)
  4. 7.3.1 Global Donepezil Sales by Country (2021-2026)
  5. 7.3.2 Global Donepezil Sales by Country (2027-2032)
  6. 7.4 Global Donepezil Sales Value by Country (2021-2032)
  7. 7.4.1 Global Donepezil Sales Value by Country (2021-2026)
  8. 7.4.2 Global Donepezil Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Donepezil Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Donepezil Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Donepezil Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Donepezil Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Donepezil Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Donepezil Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Donepezil Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Donepezil Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Donepezil Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Donepezil Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Donepezil Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Donepezil Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Donepezil Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Donepezil Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Donepezil Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Donepezil Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Donepezil Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Donepezil Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Donepezil Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Donepezil Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Donepezil Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Donepezil Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Donepezil Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Donepezil Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Donepezil Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Donepezil Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Donepezil Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Donepezil Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Donepezil Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Donepezil Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Donepezil Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Donepezil Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Donepezil Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Donepezil Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Donepezil Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Donepezil Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Donepezil Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Donepezil Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Donepezil Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Donepezil Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Donepezil Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Donepezil Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Donepezil Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Donepezil Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Donepezil Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Donepezil Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Donepezil Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Donepezil Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Donepezil Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Donepezil Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Donepezil Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Donepezil Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Donepezil Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Donepezil Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Donepezil Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Donepezil Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Donepezil Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Donepezil Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Donepezil Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Donepezil Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Donepezil Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Donepezil Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Donepezil Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Donepezil Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Donepezil Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Donepezil Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Donepezil Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Donepezil Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Donepezil Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Donepezil Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Donepezil Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Donepezil Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Donepezil Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Donepezil Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Donepezil Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Donepezil Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Donepezil Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Donepezil Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Donepezil Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Donepezil Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Donepezil Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Donepezil Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Donepezil Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Donepezil Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Donepezil Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Donepezil Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Donepezil Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Donepezil Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Donepezil Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teva Donepezil Product Portfolio
  18. 8.3.5 Teva Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Donepezil Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Donepezil Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Apotex
  26. 8.5.1 Apotex Company Information
  27. 8.5.2 Apotex Business Overview
  28. 8.5.3 Apotex Donepezil Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Apotex Donepezil Product Portfolio
  30. 8.5.5 Apotex Recent Developments
  31. 8.6 Dr Reddy's Laboratories
  32. 8.6.1 Dr Reddy's Laboratories Company Information
  33. 8.6.2 Dr Reddy's Laboratories Business Overview
  34. 8.6.3 Dr Reddy's Laboratories Donepezil Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dr Reddy's Laboratories Donepezil Product Portfolio
  36. 8.6.5 Dr Reddy's Laboratories Recent Developments
  37. 8.7 Sun Pharmaceutical
  38. 8.7.1 Sun Pharmaceutical Company Information
  39. 8.7.2 Sun Pharmaceutical Business Overview
  40. 8.7.3 Sun Pharmaceutical Donepezil Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharmaceutical Donepezil Product Portfolio
  42. 8.7.5 Sun Pharmaceutical Recent Developments
  43. 8.8 Hansoh Pharma
  44. 8.8.1 Hansoh Pharma Company Information
  45. 8.8.2 Hansoh Pharma Business Overview
  46. 8.8.3 Hansoh Pharma Donepezil Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hansoh Pharma Donepezil Product Portfolio
  48. 8.8.5 Hansoh Pharma Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Donepezil Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Donepezil Product Portfolio
  54. 8.9.5 Cipla Recent Developments
  55. 8.10 ARK PHA.LTD
  56. 8.10.1 ARK PHA.LTD Company Information
  57. 8.10.2 ARK PHA.LTD Business Overview
  58. 8.10.3 ARK PHA.LTD Donepezil Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ARK PHA.LTD Donepezil Product Portfolio
  60. 8.10.5 ARK PHA.LTD Recent Developments
  61. 8.11 Jishengtang Pharma
  62. 8.11.1 Jishengtang Pharma Company Information
  63. 8.11.2 Jishengtang Pharma Business Overview
  64. 8.11.3 Jishengtang Pharma Donepezil Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jishengtang Pharma Donepezil Product Portfolio
  66. 8.11.5 Jishengtang Pharma Recent Developments
  67. 8.12 Luoxin
  68. 8.12.1 Luoxin Company Information
  69. 8.12.2 Luoxin Business Overview
  70. 8.12.3 Luoxin Donepezil Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Luoxin Donepezil Product Portfolio
  72. 8.12.5 Luoxin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil Value Chain Analysis
  2. 9.1.1 Donepezil Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil Sales Mode & Process
  6. 9.2 Donepezil Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil Distributors
  9. 9.2.3 Donepezil Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst